Please login to the form below
Drug supply chain
This page shows the latest Drug supply chain news and features for those working in and with pharma, biotech and healthcare.
EMA to consider coronavirus' impact on EU medicines supply
The European Medicine Agency (EMA) has organised the first meeting of an executive steering group, which will address the potential impact of the novel coronavirus on the medicine supply chain in ... The US Food and Drug Administration has also said it
Latest news
-
Coronavirus outbreak escalation could impact drug supply chain
The FDA announced yesterday that it will increase its efforts to ensure the quality of ‘foreign products’, after concerns were raised that the security of the US drug supply chain could ... The FDA has acknowledged that the outbreak could affect the
-
Tit for tat as PBMs blame pharma for high drug prices
supply chain as they negotiate drug prices for health plans – are concerned that approach would wreak havoc with their business model. ... They also want more information on ‘spread pricing’, in which PBMs are said to charge different prices for
-
Confidence in UK’s post-Brexit healthcare sector on the wane
Certain events in July 2018, such as increasing concern over drug supply chain issues due to Brexit, and the political turmoil within the UK Cabinet, are likely to have been driving
-
Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on EUSA drug
Celgene’s Beck joins Orchard Therapeutics board. Promising UK cell and gene therapy company Orchard Therapeutics has bolstered its board with an experienced pharma drug development and supply chain expert, ... I look forward to working with the board
-
Trump pledges ‘total victory’ in war on drug prices
President Trump's much-anticipated speech on prescription drug prices on Friday contained plenty of anti-pharma rhetoric - but despite some concerns about proposed changes, shares in the sector rose in ... These far-reaching proposals could fundamentally
More from news
Approximately 2 fully matching, plus 13 partially matching documents found.
Latest Intelligence
-
How can virtual pharma companies de-risk new product launches?
through to marketing, supply chain design, sales, distribution and other post- launch activities. ... USA, regulated by the Drug Supply Chain Security Act (DSCSA).
-
Emerging use cases of blockchain in healthcare and the life sciences
Current processes that permit drug provenance and supply chain tracking are fragmented due to data silos, which can lead to human errors and fraud such as drug counterfeiting. ... Another example is the MediLedger Project, which brings together a
-
The logistics of orphan drugs
In many cases, the patient is in dire need of the drug and so the supply chain must operate at a much more rapid pace. ... When managing global access programmes it is important to maintain complete visibility of all steps in the supply chain along with
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- 2023 PM Society Awards – winners announced
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Amgen gets block on sales of Repatha rival in Germany
- Congress is in session – how companies are boosting their impact and engagement
- The state of pharma customer experience
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
